What is Ventas, Inc. (VTR) DCF Fair Value and Intrinsic Value in 2026?

Ventas, Inc. (VTR) intrinsic value is calculated using conservative multi-stage Discounted Cash Flow (DCF) models, 5-year free cash flow trajectories, Graham Numbers, and owner earnings multiples. LocalAlpha tracks real-time margin of safety against live market prices.

What is Ventas, Inc.'s historical Return on Invested Capital (ROIC) and Moat Rating?

Ventas, Inc. operates in the Real Estate sector (REIT - Healthcare Facilities) with an economic moat rating of NONE. LocalAlpha tracks 5-year audited quarterly ROIC, operating margin stability, and balance sheet solvency ratios.

What is Ventas, Inc.'s financial health rating and Piotroski F-Score?

Ventas, Inc.'s balance sheet quality is evaluated using the 9-point Piotroski F-Score, Altman Z-Score solvency model, debt-to-equity ratio, and quick/current liquidity coverage to guard against financial distress.

How does LocalAlpha monitor Ventas, Inc. (VTR) for quarterly SEC filing thesis breaks?

LocalAlpha audits Ventas, Inc.'s 10-K, 10-Q, and 8-K regulatory filings on SEC EDGAR within 15 minutes of release. If reported metrics breach an investor's custom ROIC floor, operating margin boundary, or qualitative risk criteria, an autonomous breach audit is dispatched immediately.

StocksVTR

VTR

Ventas, Inc.Real Estate / REIT - Healthcare FacilitiesINTACT

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company's growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments. Ventas aims to deliver outsized performance by leveraging its operational expertise, data-driven insights from its Ventas OITM platform, extensive relationships and strong financial position. The Ventas portfolio also includes outpatient medical buildings, research centers and healthcare facilities. Ventas, Inc. is based in Illinois, Chicago. Ventas, Inc. was incorporated in 1983 in Maryland.

Share Price

$90.40

52W: $66.54 - $101.6

DCF Fair Value

$35.34

-155.8% Premium

Thesis Hub

P/E (TTM)

164.4x

ROIC

11.1%

Operating Margin

14.8%

FCF Yield

3.2%

Debt / Equity

0.85x

Piotroski Score

7/9

Altman Z-Score

3.02

Market Cap

$46.4B

Price vs. Intrinsic Value Corridor

Overvalued vs DCF ($35.34)

Historical market price overlaid against conservative DCF Fair Value & Benjamin Graham Margin of Safety bands.

Period Return (1Y)

—()

Period Range

$— - $—

DCF Fair Value

$35.34

MOS Buy Target (-25%)

$26.51

Valuation Overlays: DCF Fair Value ($35.34) 25% MOS Buy Target ($26.51) Revised Graham ($9.88) Graham Number ($18.80)

2-Stage Discounted Cash Flow (DCF) Workbench

Conservative intrinsic value model based on owner cash generation over a 10-year investment horizon. Opens with LocalAlpha's baseline assumptions (matching the fair value shown above) — adjust any input to stress-test.

Current Market Price

$90.40

DCF Fair Value

$35.38

-155.5% Premium

Starting Free Cash Flow ($M)$1,487M

$100M$1,487M (Reported)$50,000M

Stage 1 Growth (Years 1-5)7.4%

-5%10% (Target)35%

Stage 2 Growth (Years 6-10)4.5%

0%5%20%

Discount Rate (WACC / Hurdle)9.0%

6%9% (Standard)15% (High Risk)

Terminal Perpetual Growth2.5%

1% (GDP Floor)2.5% (Inflation)4.0%

Net Debt ($M)$12,700M

-$100B CashBalance Sheet+$150B Debt

10-Yr PV of Cash Flows

$13.2B

PV of Terminal Value

$17.6B

Implied Enterprise Value

$30.8B

Implied Equity Value

$18.1B

Year	Yr 1	Yr 2	Yr 3	Yr 4	Yr 5	Yr 6	Yr 7	Yr 8	Yr 9	Yr 10
Projected FCF ($M)	$1,597	$1,715	$1,842	$1,978	$2,125	$2,220	$2,320	$2,425	$2,534	$2,648
Present Value (PV)	$1,465	$1,444	$1,422	$1,402	$1,381	$1,324	$1,269	$1,217	$1,167	$1,119

Benjamin Graham & Buffett Value Models

Classical deep value metrics based on asset backing, normalized earnings power, and owner cash yield.

Graham Number-380.9% Premium

$18.80

Calculated as √(22.5 × EPS × BVPS). The maximum theoretical price a defensive investor should pay based purely on asset book value and current earnings.

EPS: $0.55BVPS: $28.56

Revised Graham Formula-815% Premium

$9.88

Formula: V = (EPS × (8.5 + 2g) × 4.4) / Y where g is the conservative 7-10 yr growth rate and Y is AAA Bond Yield.

Growth Rate (g%)

Bond Yield (Y%)

Buffett Owner Earnings3% Yield

$2.75 / share

True distributable cash flow: Net Income + D&A - Maintenance CapEx. Reflects the cash Buffett would extract without hurting unit volume.

Total: $1.4BYield: 3%

Reverse DCF: Market Growth Expectation

FAIR BARRIER

11.5% CAGR (Next 10 Yrs)

At the current price of $90.40, the market is assuming the business will compound Free Cash Flow at 11.5% per year for the next decade with a 9% hurdle rate.

Value Investor Verdict

ℹ Fair expectations: Requires steady execution.

Autonomous Thesis Underwriting

Surveil VTR with Mathematical Margin of Safety Rules

Set non-negotiable floor rules for Ventas, Inc.. If a newly filed quarterly 10-Q breaks your ROIC floor, operating margin boundary, or balance sheet leverage rules, receive an autonomous breach audit within 15 minutes.

Buffett Quality

ROIC > 15% • Margin > 15% • D/E < 0.5x

Margin Floor Guard

Current Margin 14.8% • Floor > 10%

Solvency Guard

Altman-Z > 2.6 • Current Ratio > 1.5x

Track VTR & Set Alerts Browse S&P 500 Coverage

Frequently Asked Questions: Ventas, Inc. (VTR) Intrinsic Valuation

Audited fundamentals, DCF intrinsic value sensitivity, and thesis break detection parameters for Ventas, Inc..

Based on institutional multi-stage Discounted Cash Flow (DCF) modeling on audited SEC cash flows, Ventas, Inc. has an estimated DCF intrinsic fair value of $35.34 per share compared to its current market price of $90.40. This represents an estimated 155.8% premium over fair value. Additionally, its classic Benjamin Graham Number stands at $18.80.